Orocal


Indications and Reactions:

Role Indications Reactions
Primary
Sciatica 100.0%
Hydrocholecystis 100.0%
Secondary
Drug Use For Unknown Indication 36.3%
Product Used For Unknown Indication 21.1%
Rheumatoid Arthritis 5.9%
Benign Prostatic Hyperplasia 4.9%
Insomnia 3.9%
Proctocolitis 3.9%
Drug Exposure During Pregnancy 2.9%
Hypertension 2.9%
Bronchitis 2.5%
Essential Hypertension 2.5%
Rhinitis Allergic 2.5%
Prophylaxis 2.0%
Sciatica 2.0%
Dialysis 1.5%
Pain 1.5%
Herpes Virus Infection 1.0%
Renal Failure 1.0%
Systemic Lupus Erythematosus 1.0%
Bone Density Decreased 0.5%
Colitis Ulcerative 0.5%
Intravascular Haemolysis 23.3%
Rhabdomyolysis 14.0%
Renal Failure 11.6%
Cholestasis 7.0%
Gingivitis Ulcerative 4.7%
Intra-uterine Death 4.7%
Tachycardia 4.7%
Blood Lactic Acid Increased 2.3%
Confusional State 2.3%
Herpes Virus Infection 2.3%
Hypertension 2.3%
Hyponatraemia 2.3%
Injury 2.3%
Jaundice 2.3%
Limb Malformation 2.3%
Pancreatitis Necrotising 2.3%
Periodontal Destruction 2.3%
Pregnancy 2.3%
Premature Baby 2.3%
Procedural Hypertension 2.3%
Concomitant
Drug Use For Unknown Indication 21.9%
Product Used For Unknown Indication 21.5%
Rheumatoid Arthritis 17.4%
Osteoporosis 12.2%
Hypertension 2.9%
Osteoporosis Prophylaxis 2.9%
Renal Transplant 2.9%
Depression 2.2%
Anxiety 2.1%
Asthma 1.6%
Bronchitis 1.6%
Head Injury 1.6%
Atrial Fibrillation 1.2%
Essential Hypertension 1.2%
Gastrooesophageal Reflux Disease 1.2%
Mineral Supplementation 1.2%
Multiple Sclerosis 1.2%
Systemic Lupus Erythematosus 1.2%
Thyroiditis 1.1%
Prophylaxis 0.9%
Renal Failure Acute 13.3%
Vertigo 13.3%
Premature Baby 6.7%
Toxic Skin Eruption 6.7%
Drug Exposure During Pregnancy 5.6%
Blood Creatinine Increased 4.4%
Sudden Death 4.4%
Urinary Tract Infection 4.4%
Vomiting 4.4%
Hypertensive Crisis 3.3%
Injury 3.3%
International Normalised Ratio Increased 3.3%
Lung Disorder 3.3%
Muscle Haemorrhage 3.3%
Myocarditis 3.3%
Neutropenia 3.3%
Off Label Use 3.3%
Polyhydramnios 3.3%
Renal Failure 3.3%
Retinopathy 3.3%

Drug Data